New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 16, 2019 - The FDA announced the discontinuation of Merck’s Rebetol (ribavirin) oral solution.
Download PDF
Return to publications
